Cargando…
Overcoming Drug Interference in Transfusion Testing: A Spotlight on Daratumumab
Daratumumab, a monoclonal antibody therapeutic, is highly efficacious and widely used in all stages of multiple myeloma and amyloidosis and has promising activity in other hematologic disorders. Daratumumab interacts with red blood cells, interfering with pre-transfusion testing. This interference c...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164699/ https://www.ncbi.nlm.nih.gov/pubmed/34079412 http://dx.doi.org/10.2147/JBM.S213510 |